QIAGEN N.V. QGEN is well-poised to grow in the coming quarter, driven by its strategic alliances with researchers and pharma companies. The company’s expansive next-generation sequencing (NSG) ...

QIAGEN N.V. QGEN recently signed a definitive agreement to acquire Genoox, a provider of AI-powered software that enables clinical labs to scale and accelerate the processing of complex genetic tests.

Qiagen ( (QGEN)) has issued an announcement. QIAGEN has disclosed a managers’ transaction involving Roland Sackers, a member of its managing body, under market abuse regulations. The transaction ...

QIAGEN N.V. QGEN is well poised for growth in the coming months, backed by its expansion in testing solutions. The company’s strategic collaboration is expected to drive growth further. However, ...

Qiagen (QGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

An update from Qiagen ( (QGEN)) is now available. Qiagen has disclosed a managers’ transaction under EU market abuse regulations involving supervisory board member Eva van Pelt. She received a grant ...